Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers
作者:Ahmed M. Sh. El-Sharief、Yousry A. Ammar、Amany Belal、Marwa A.M. Sh. El-Sharief、Yehia A. Mohamed、Ahmed B.M. Mehany、Gameel A.M. Elhag Ali、Ahmed Ragab
DOI:10.1016/j.bioorg.2019.01.016
日期:2019.4
13C NMR and elemental analysis. Anticancer activity against three cancer cell lines (HepG-2, HCT-116 and MCF-7) were evaluated using sulforhodamine B assay method. Compounds 4b, 4c, 7a, 7c and 9 showed broad spectrum anticancer activity on the three tested cell lines with IC50 values less than 10 µM. Cell cycle analysis was performed for the most promising derivatives, compounds 4b and 7c arrested HepG-2
5-吗啉代磺酰赖氨酸(1)与苯乙酮(2a-e)反应,得到3-羟基-3-取代的-2-氧代吲哚3a-e,当用乙酸处理时,预期的3-苯乙叉基-2-氧代吲哚4a-d和4得到-羟基-5'-(吗啉磺酰基)螺[色烯-2,3'-吲哚啉] -2'-一6。将Isatin衍生物(1)与氰基衍生物搅拌,生成芳基化合物(7a-c),同时在回流条件下,得到吡咯并[2,3-b]吲哚(8,9)。此外,伊斯丹(1)在丙二腈的存在下与吡唑并-5-酮或3-取代的苯酚反应,得到螺并吲哚衍生物(10a,b)和(11a,b)。另外,通过将(7a)与吡唑并-5-酮或3-取代的苯酚环合而获得化合物(10a,b)和(11a,b)。通过IR,1 H NMR,13 C NMR和元素分析鉴定所获得的化合物。使用磺基罗丹明B测定法评估了对三种癌细胞系(HepG-2,HCT-116和MCF-7)的抗癌活性。化合物4b,4c,7a,7c和9对三种测试